Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Barberis

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
American Journal of Clinical Pathology|September 20, 2015
Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle AspirationChiara Casadio, Juliana Guarize, Stefano Donghi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumorsFrancesca Toffalorio, Filippo de Marinis, Fabio Conforti, et al.
Breast Cancer Research : BCR|October 16, 2020
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapsesCaterina Fumagalli, Alberto Ranghiero, Sara Gandini, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|July 14, 2021
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot studyJuliana Guarize, Elena Guerini Rocco, Filippo de Marinis, et al.
Cancers|October 27, 2019
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor TherapyCaterina Fumagalli, Federica Tomao, Ilaria Betella, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)Alice Laffi, Marzia Colandrea, Giuseppe Buonsanti, et al.
Oncotargets and Therapy|May 24, 2014
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642EChiara Catania, Fabio Conforti, Gianluca Spitaleri, et al.
Endocrine|July 24, 2020
Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysisFrancesca Spada, Patrick Maisonneuve, Caterina Fumagalli, et al.
Anticancer Research|January 2, 2020
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective AnalysisLetizia Gianoncelli, Gianluca Spitaleri, Antonio Passaro, et al.
The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
American Journal of Clinical Pathology|September 20, 2015
Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle AspirationChiara Casadio, Juliana Guarize, Stefano Donghi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumorsFrancesca Toffalorio, Filippo de Marinis, Fabio Conforti, et al.
Breast Cancer Research : BCR|October 16, 2020
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapsesCaterina Fumagalli, Alberto Ranghiero, Sara Gandini, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|July 14, 2021
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot studyJuliana Guarize, Elena Guerini Rocco, Filippo de Marinis, et al.
Cancers|October 27, 2019
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor TherapyCaterina Fumagalli, Federica Tomao, Ilaria Betella, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)Alice Laffi, Marzia Colandrea, Giuseppe Buonsanti, et al.
Oncotargets and Therapy|May 24, 2014
Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642EChiara Catania, Fabio Conforti, Gianluca Spitaleri, et al.
Endocrine|July 24, 2020
Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysisFrancesca Spada, Patrick Maisonneuve, Caterina Fumagalli, et al.
Anticancer Research|January 2, 2020
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective AnalysisLetizia Gianoncelli, Gianluca Spitaleri, Antonio Passaro, et al.
The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
Pageof 17